PT2895465T - Composições parasiticidas compreendendo derivados de benzimidazoles, os seus métodos e as suas utilizações - Google Patents

Composições parasiticidas compreendendo derivados de benzimidazoles, os seus métodos e as suas utilizações

Info

Publication number: PT2895465T
Authority: PT; Portugal
Prior art keywords: methods; benzimidazole derivatives; parasiticidal compositions; parasiticidal; compositions
Prior art date: 2012-04-20

Application number

PT13719345T

Other languages

English (en)

Portuguese (pt)

Inventor

Q Meng Charles

Original Assignee

Boehringer Ingelheim Animal Health Usa Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-04-20

Filing date

2013-04-18

Publication date

2019-01-16

2013-04-18 Application filed by Boehringer Ingelheim Animal Health Usa Inc filed Critical Boehringer Ingelheim Animal Health Usa Inc

2019-01-16 Publication of PT2895465T publication Critical patent/PT2895465T/pt

Links

229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1
239000000203 mixture Substances 0.000 title 1
230000000590 parasiticidal effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/10—Radicals substituted by halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Tropical Medicine & Parasitology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

PT13719345T 2012-04-20 2013-04-18 Composições parasiticidas compreendendo derivados de benzimidazoles, os seus métodos e as suas utilizações PT2895465T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201261635961P	2012-04-20	2012-04-20

Publications (1)

Publication Number	Publication Date
PT2895465T true PT2895465T (pt)	2019-01-16

Family

ID=48225136

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT13719345T PT2895465T (pt)	2012-04-20	2013-04-18	Composições parasiticidas compreendendo derivados de benzimidazoles, os seus métodos e as suas utilizações

Country Status (23)

Country	Link
US (3)	US9000187B2 (fr)
EP (3)	EP3453702A3 (fr)
JP (4)	JP6161173B2 (fr)
KR (3)	KR102160889B1 (fr)
CN (4)	CN105884693B (fr)
AR (1)	AR090766A1 (fr)
AU (2)	AU2013249217B2 (fr)
BR (3)	BR122015032741B1 (fr)
CA (2)	CA3059936A1 (fr)
CL (3)	CL2014002831A1 (fr)
CO (1)	CO7151497A2 (fr)
EA (1)	EA028430B1 (fr)
ES (1)	ES2703535T3 (fr)
IL (3)	IL235107A (fr)
MX (3)	MX351636B (fr)
NZ (3)	NZ701185A (fr)
PH (1)	PH12014502345A1 (fr)
PT (1)	PT2895465T (fr)
SG (3)	SG10201700291VA (fr)
UA (1)	UA115981C2 (fr)
UY (1)	UY34761A (fr)
WO (1)	WO2013158894A1 (fr)
ZA (1)	ZA201407605B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3157912B1 (fr) *	2014-06-19	2019-02-20	Merial, Inc.	Compositions parasiticides comprenant des dérivés d'indole, leurs procédés et leurs utilisations
EP4272550A3 (fr)	2016-03-31	2024-05-15	Boehringer Ingelheim Vetmedica GmbH	Système d'ètiquetage pour le suivi d'un animal
CN106496037A (zh) *	2016-10-20	2017-03-15	上海毕得医药科技有限公司	一种1,4‑二碘‑2‑甲氧基‑5‑硝基苯的合成方法
KR102147235B1 (ko) *	2018-05-18	2020-08-24	연세대학교 산학협력단	발광성, 강유전성 및 압전성을 나타내는 헤테로아릴 화합물 및 이를 포함하는 전자소자
GB201811695D0 (en)	2018-07-17	2018-08-29	Salvensis	Compounds for use in the treatment of fascioliasis
AU2023316589A1 (en) *	2022-07-26	2025-02-06	Rush University Medical Center	Compounds and methods for the treatment of diseases associated with parasitic worms

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB955961A (en) *	1959-09-24	1964-04-22	Gevaert Photo Prod Nv	Benzimidazole derivatives
NL277327A (fr) *	1961-04-24
IL22272A (en) *	1963-11-06	1969-02-27	Merck & Co Inc	2-heteroaryl-5(or 6)-aryl substituted benzazoles
US3578675A (en) *	1969-06-09	1971-05-11	Merck & Co Inc	2-(3'-fluoro-2'-naphthyl)-benzimidazoles
US3749789A (en)	1970-02-27	1973-07-31	Merck & Co Inc	Anthelmintic compositions containing benzimidazoles and method of use
DE2016622A1 (en) *	1970-04-08	1971-10-21	Farbenfabriken Bayer Ag, 5090 Leverkusen	Anthelmintic benzimidazole deriv
NL160809C (nl)	1970-05-15	1979-12-17	Duphar Int Res	Werkwijze ter bereiding van benzoylureumverbindingen, alsmede werkwijze ter bereiding van insekticide prepara- ten op basis van benzoylureumverbindingen.
JPS4914624A (fr)	1972-06-08	1974-02-08
US3950360A (en)	1972-06-08	1976-04-13	Sankyo Company Limited	Antibiotic substances
US3818047A (en)	1972-08-07	1974-06-18	C Henrick	Substituted pyrones
US3815047A (en)	1973-02-14	1974-06-04	Bell Telephone Labor Inc	Transversely-excited waveguide gas laser
US4336262A (en)	1973-02-23	1982-06-22	Fisons Ltd.	Pour-on veterinary anthelmintic
DK645374A (fr) *	1974-01-22	1975-09-29	Ciba Geigy Ag
SE434277B (sv)	1976-04-19	1984-07-16	Merck & Co Inc	Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
CH604517A5 (fr)	1976-08-19	1978-09-15	Ciba Geigy Ag
US4134973A (en)	1977-04-11	1979-01-16	Merck & Co., Inc.	Carbohydrate derivatives of milbemycin and processes therefor
CH634307A5 (de)	1977-04-12	1983-01-31	Ciba Geigy Ag	Anthelmintisch wirkende benzimidazolderivate, verfahren zu ihrer herstellung und mittel enthaltend diese wirkstoffe.
US4197307A (en) *	1977-04-12	1980-04-08	Ciba-Geigy Corporation	2-Alkylthio-, 2-alkylsulphinyl- and 2-alkylsulfonyl-6-phenylbenzimidazoles as anthelmintic agents
US4199569A (en)	1977-10-03	1980-04-22	Merck & Co., Inc.	Selective hydrogenation products of C-076 compounds and derivatives thereof
US4144352A (en)	1977-12-19	1979-03-13	Merck & Co., Inc.	Milbemycin compounds as anthelmintic agents
US4203976A (en)	1978-08-02	1980-05-20	Merck & Co., Inc.	Sugar derivatives of C-076 compounds
DE2840927A1 (de) *	1978-09-20	1980-04-10	Bayer Ag	3,4-dihydroisochinoline, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CH642359A5 (en) *	1978-10-02	1984-04-13	Ciba Geigy Ag	Benzimidazole derivatives
JPS57139012A (en)	1981-02-23	1982-08-27	Sankyo Co Ltd	Anthelmintic composition
US4427663A (en)	1982-03-16	1984-01-24	Merck & Co., Inc.	4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
JPS59199673A (ja)	1983-04-25	1984-11-12	Sumitomo Chem Co Ltd	含窒素複素環化合物、その製造法およびそれを有効成分とする有害生物防除剤
EP0179022B1 (fr)	1984-10-18	1990-11-07	Ciba-Geigy Ag	Benzoylphénylurées
DE3681465D1 (fr)	1985-02-04	1991-10-24	Nihon Bayer Agrochem K.K., Tokio/Tokyo, Jp
EP0237482A1 (fr)	1986-03-06	1987-09-16	Ciba-Geigy Ag	Dérivés de la C(29)-carbonyloxy-milbémycine pour la lutte contre les parasites d'espèces végétales ou animales
DE3785936T2 (de)	1986-03-25	1993-08-26	Sankyo Co	Makrolid-derivate, ihre herstellung und ihre verwendung.
EP0252879B1 (fr)	1986-07-02	1992-05-06	Ciba-Geigy Ag	Pesticides
US4855317A (en)	1987-03-06	1989-08-08	Ciba-Geigy Corporation	Insecticides and parasiticides
US4871719A (en)	1987-03-24	1989-10-03	Ciba-Geigy Corporation	Composition for controlling parasites in productive livestock
US4874749A (en)	1987-07-31	1989-10-17	Merck & Co., Inc.	4"-Deoxy-4-N-methylamino avermectin Bla/Blb
JPS6435773A (en)	1987-07-31	1989-02-06	Nippon Denki Home Electronics	Signal frequency discriminating device
DE3888936T2 (de)	1987-11-03	1994-07-21	Beecham Group Plc	Zwischenprodukte für die Herstellung makrolider Antibiotika mit anthelmintischer Wirkung.
JP2695419B2 (ja) *	1987-11-20	1997-12-24	工業技術院長	２−（ポリフルオロアルキル）ハロゲノベンズイミダゾール類、その製造法およびそれを有効成分とする殺虫、殺ダニ剤
NZ232422A (en)	1989-02-16	1992-11-25	Merck & Co Inc	13-ketal milbemycin derivatives and parasiticides
NZ232785A (en) *	1989-03-15	1991-03-26	Janssen Pharmaceutica Nv	5-(1,2 benzisoxazol-, benzimidazol and benzisothiazol-3- yl)-1h-benzimadazol-2-yl carbamic acid ester derivatives preparatory processes, intermediates and anthelmintic compositions
IE904606A1 (en)	1989-12-21	1991-07-03	Beecham Group Plc	Novel products
NZ247278A (en)	1991-02-12	1995-03-28	Ancare Distributors	Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier
WO1992022555A1 (fr)	1991-06-17	1992-12-23	Beecham Group Plc	Derives de paraherquamide, precurseur de ces derives, procedes de preparation, microorganisme utilise et utilisation de ces derives comme agents parasiticides
US5278181A (en) *	1992-05-12	1994-01-11	Board Of Regents Acting On Behalf Of The University Of Michigan	Soluble alkyl[5-[amino (phenyl)methyl]-1H-benzimidazol-2-yl] carbamate anthelmintics
US5345377A (en)	1992-10-30	1994-09-06	Electric Power Research Institute, Inc.	Harmonic controller for an active power line conditioner
GB9300883D0 (en)	1993-01-18	1993-03-10	Pfizer Ltd	Antiparasitic agents
US5399582A (en)	1993-11-01	1995-03-21	Merck & Co., Inc.	Antiparasitic agents
AUPM969994A0 (en)	1994-11-28	1994-12-22	Virbac S.A.	Equine anthelmintic formulations
US5962499A (en)	1995-03-20	1999-10-05	Merck & Co., Inc.	Nodulisporic acid derivatives
US6221894B1 (en)	1995-03-20	2001-04-24	Merck & Co., Inc.	Nodulisporic acid derivatives
MY113806A (en)	1995-07-21	2002-05-31	Upjohn Co	Antiparasitic marcfortines and paraherquamides
IE80657B1 (en)	1996-03-29	1998-11-04	Merial Sas	Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
US6207647B1 (en)	1997-07-18	2001-03-27	Smithkline Beecham Corporation	RatA
JPH1135773A (ja) *	1997-07-23	1999-02-09	Nippon Synthetic Chem Ind Co Ltd:The	エチレン−酢酸ビニル系共重合体ケン化物組成物及びその成形物
PE20011289A1 (es)	2000-04-07	2001-12-21	Upjohn Co	Composiciones antihelminticas que comprenden lactonas macrociclicas y espirodioxepinoindoles
US6399786B1 (en)	2000-07-14	2002-06-04	Merck & Co., Inc.	Nonacyclic nodulisporic acid derivatives
TW200300140A (en) *	2001-11-14	2003-05-16	Novartis Ag	Organic compounds
AR042420A1 (es)	2002-09-11	2005-06-22	Novartis Ag	Benzotriazolil- aminoacetonitril compuestos, proceso para su preparacion, metodo y uso de los mismos en el control de endo- y ecto-parasitos dentro y sobre ganado productor de sangre caliente y animales domesticos y plantas, y en la preparacion de una composicion farmaceutica
US7396819B2 (en)	2003-08-08	2008-07-08	Virbac Corporation	Anthelmintic formulations
CN101768129B (zh)	2004-03-05	2012-05-23	日产化学工业株式会社	异*唑啉取代苯甲酰胺化合物的制备中间体
WO2006050148A2 (fr) *	2004-10-29	2006-05-11	Teva Pharmaceutical Industries, Ltd.	Derives de propargyl-trifluoromethoxy-aminobenzimidazole
EP1849465A4 (fr) *	2005-02-18	2008-12-24	Takeda Pharmaceutical	Agent de controle de la fonction du recepteur gpr34
JP2009519937A (ja)	2005-12-14	2009-05-21	イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー	無脊椎有害生物防除用イソオキサゾリン
TW200803740A (en)	2005-12-16	2008-01-16	Du Pont	5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh)	2005-12-30	2013-10-21	Du Pont	控制無脊椎害蟲之異唑啉
EP2465851A1 (fr) *	2006-07-05	2012-06-20	Aventis Agriculture	Composés dérivés de 1-aryl-5-alkyl pyrazole, leurs procédés de fabrication et leurs procédés d'utilisation
JP2009023986A (ja) *	2006-11-08	2009-02-05	Pharma Ip	抗癌剤としてのビアリール誘導体
MY146638A (en)	2007-04-10	2012-09-14	Bayer Cropscience Ag	Insecticidal aryl isoxazoline derivatives
RS55271B1 (sr)	2007-05-15	2017-02-28	Merial Sas	Ariloazol-2-il cijanoetilamino jedinjenja, postupci dobijanja i postupci njihove primene
TWI430995B (zh)	2007-06-26	2014-03-21	Du Pont	萘異唑啉無脊椎有害動物控制劑
KR101769728B1 (ko)	2007-06-27	2017-08-18	이 아이 듀폰 디 네모아 앤드 캄파니	동물 해충 방제 방법
ES2423505T3 (es)	2007-06-29	2013-09-20	Zoetis Llc	Combinación antihelmíntica
TWI556741B (zh)	2007-08-17	2016-11-11	英特威特國際股份有限公司	異唑啉組成物及其作為抗寄生蟲藥上的應用
TW201111358A (en) *	2009-06-18	2011-04-01	Intervet Int Bv	Anthelmintic agents and their use

2013
- 2013-04-18 BR BR122015032741A patent/BR122015032741B1/pt not_active IP Right Cessation
- 2013-04-18 US US13/865,802 patent/US9000187B2/en active Active
- 2013-04-18 CA CA3059936A patent/CA3059936A1/fr not_active Abandoned
- 2013-04-18 CN CN201610238042.8A patent/CN105884693B/zh active Active
- 2013-04-18 EA EA201401160A patent/EA028430B1/ru unknown
- 2013-04-18 EP EP18186136.0A patent/EP3453702A3/fr not_active Withdrawn
- 2013-04-18 MX MX2017002458A patent/MX351636B/es unknown
- 2013-04-18 AU AU2013249217A patent/AU2013249217B2/en active Active
- 2013-04-18 CA CA2870956A patent/CA2870956C/fr not_active Expired - Fee Related
- 2013-04-18 NZ NZ701185A patent/NZ701185A/en unknown
- 2013-04-18 SG SG10201700291VA patent/SG10201700291VA/en unknown
- 2013-04-18 SG SG11201406730RA patent/SG11201406730RA/en unknown
- 2013-04-18 NZ NZ711847A patent/NZ711847A/en unknown
- 2013-04-18 KR KR1020197038041A patent/KR102160889B1/ko not_active Expired - Fee Related
- 2013-04-18 BR BR122015032742A patent/BR122015032742B1/pt not_active IP Right Cessation
- 2013-04-18 CN CN201710658168.5A patent/CN107353254A/zh active Pending
- 2013-04-18 EP EP13719345.4A patent/EP2895465B1/fr active Active
- 2013-04-18 SG SG10201704665QA patent/SG10201704665QA/en unknown
- 2013-04-18 PT PT13719345T patent/PT2895465T/pt unknown
- 2013-04-18 CN CN201610238035.8A patent/CN105732511B/zh active Active
- 2013-04-18 MX MX2017012361A patent/MX367536B/es unknown
- 2013-04-18 WO PCT/US2013/037193 patent/WO2013158894A1/fr not_active Ceased
- 2013-04-18 JP JP2015507181A patent/JP6161173B2/ja not_active Expired - Fee Related
- 2013-04-18 BR BR112014026184-9A patent/BR112014026184B1/pt not_active IP Right Cessation
- 2013-04-18 KR KR1020197028105A patent/KR102114598B1/ko not_active Expired - Fee Related
- 2013-04-18 KR KR1020147032382A patent/KR102160836B1/ko not_active Expired - Fee Related
- 2013-04-18 CN CN201380028145.6A patent/CN104395295B/zh active Active
- 2013-04-18 EP EP20179838.6A patent/EP3763706A1/fr not_active Withdrawn
- 2013-04-18 UA UAA201412418A patent/UA115981C2/uk unknown
- 2013-04-18 NZ NZ709589A patent/NZ709589A/en unknown
- 2013-04-18 MX MX2014012713A patent/MX345971B/es active IP Right Grant
- 2013-04-18 ES ES13719345T patent/ES2703535T3/es active Active
- 2013-04-19 AR ARP130101311A patent/AR090766A1/es active IP Right Grant
- 2013-04-23 UY UY0001034761A patent/UY34761A/es not_active Application Discontinuation
2014
- 2014-10-19 IL IL235107A patent/IL235107A/en active IP Right Grant
- 2014-10-20 PH PH12014502345A patent/PH12014502345A1/en unknown
- 2014-10-20 CL CL2014002831A patent/CL2014002831A1/es unknown
- 2014-10-20 ZA ZA2014/07605A patent/ZA201407605B/en unknown
- 2014-11-20 CO CO14255097A patent/CO7151497A2/es unknown
2015
- 2015-02-20 US US14/627,595 patent/US9359305B2/en active Active
- 2015-12-08 IL IL242980A patent/IL242980A/en active IP Right Grant
2016
- 2016-03-18 JP JP2016054730A patent/JP6124321B2/ja not_active Expired - Fee Related
- 2016-03-18 JP JP2016054729A patent/JP6213852B2/ja not_active Expired - Fee Related
- 2016-05-06 US US15/148,168 patent/US9695129B2/en active Active
2017
- 2017-03-15 IL IL251177A patent/IL251177B/en active IP Right Grant
- 2017-04-05 JP JP2017075054A patent/JP6246405B2/ja not_active Expired - Fee Related
- 2017-04-26 AU AU2017202719A patent/AU2017202719A1/en not_active Abandoned
- 2017-05-15 CL CL2017001239A patent/CL2017001239A1/es unknown
2018
- 2018-12-14 CL CL2018003596A patent/CL2018003596A1/es unknown

Also Published As

Publication number	Publication date
SG11201406730RA (en)	2014-11-27
JP2017119716A (ja)	2017-07-06
ZA201407605B (en)	2015-11-25
HK1211580A1 (en)	2016-05-27
PH12014502345B1 (en)	2014-12-22
MX345971B (es)	2017-02-28
EP3453702A2 (fr)	2019-03-13
WO2013158894A1 (fr)	2013-10-24
IL235107A (en)	2017-09-28
US9695129B2 (en)	2017-07-04
CN105884693A (zh)	2016-08-24
BR122015032742B1 (pt)	2020-04-07
CO7151497A2 (es)	2014-12-29
NZ711847A (en)	2015-11-27
JP2015516977A (ja)	2015-06-18
CA2870956C (fr)	2020-03-31
US9359305B2 (en)	2016-06-07
CN105884693B (zh)	2019-11-01
CL2018003596A1 (es)	2019-01-25
UY34761A (es)	2013-11-29
IL251177B (en)	2018-03-29
EA028430B1 (ru)	2017-11-30
MX351636B (es)	2017-10-23
BR122015032742A2 (pt)	2018-12-11
US20150166485A1 (en)	2015-06-18
CN104395295B (zh)	2018-03-06
AU2017202719A1 (en)	2017-05-18
JP6124321B2 (ja)	2017-05-10
SG10201704665QA (en)	2017-07-28
KR20190114002A (ko)	2019-10-08
CA2870956A1 (fr)	2013-10-24
JP6161173B2 (ja)	2017-07-12
AU2013249217A1 (en)	2014-11-06
CN105732511A (zh)	2016-07-06
JP2016155837A (ja)	2016-09-01
BR122015032741B1 (pt)	2019-11-26
JP6213852B2 (ja)	2017-10-18
KR20150002853A (ko)	2015-01-07
KR102114598B1 (ko)	2020-05-25
IL242980A (en)	2017-08-31
PH12014502345A1 (en)	2014-12-22
EP3763706A1 (fr)	2021-01-13
MX2014012713A (es)	2015-01-19
KR102160889B1 (ko)	2020-09-28
SG10201700291VA (en)	2017-03-30
EP2895465B1 (fr)	2018-10-03
JP6246405B2 (ja)	2017-12-13
ES2703535T3 (es)	2019-03-11
JP2016106154A (ja)	2016-06-16
CL2017001239A1 (es)	2017-12-11
EP2895465A1 (fr)	2015-07-22
CA3059936A1 (fr)	2013-10-24
US20160251317A1 (en)	2016-09-01
CL2014002831A1 (es)	2014-12-12
KR20200000470A (ko)	2020-01-02
NZ709589A (en)	2015-10-30
CN104395295A (zh)	2015-03-04
AR090766A1 (es)	2014-12-03
CN105732511B (zh)	2018-08-17
NZ701185A (en)	2015-08-28
AU2013249217B2 (en)	2017-04-27
US20130281392A1 (en)	2013-10-24
BR112014026184B1 (pt)	2019-04-24
BR122015032741A2 (pt)	2019-08-27
MX367536B (es)	2019-08-26
KR102160836B1 (ko)	2020-09-28
US9000187B2 (en)	2015-04-07
EP3453702A3 (fr)	2019-05-15
BR112014026184A2 (pt)	2017-06-27
IL251177A0 (en)	2017-05-29
UA115981C2 (uk)	2018-01-25
EA201401160A1 (ru)	2015-04-30
CN107353254A (zh)	2017-11-17

Publication	Publication Date	Title
IL238958A0 (en)	2015-07-30	Glutamase inhibitors, preparations containing them and their uses
IL234014A0 (en)	2014-09-30	Cycloalkane derivatives, preparations containing them and their uses
GB2514951C (en)	2020-11-04	Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
IL238959A0 (en)	2015-07-30	Glutamase inhibitors, preparations containing them and their uses
IL233863A0 (en)	2014-09-30	Pyridine derivatives, preparations containing them and their uses
IL239481A0 (en)	2015-07-30	Compounds derived from mannose, preparations containing them and their uses
IL232217A (en)	2017-02-28	Derivatives of Azul, pharmaceutical preparations containing them and their use
IL236057B (en)	2018-08-30	History of 4,2,1-triazine-6-carboxamide and pharmaceutical preparations containing them
IL233824A (en)	2016-09-29	Compounds 1h - Indazole - 3 - Carboxamide, preparations containing them and their use
IL236712A0 (en)	2015-02-26	Di-teri-heteroaryl derivatives, preparations containing them and their uses
IL239327A (en)	2017-11-30	Tetrazole derivatives in solid dispersion, preparations containing them and their uses
IL251177A0 (en)	2017-05-29	Parasitic preparations containing benzaimidazole history, methods and uses
IL237542B (en)	2019-05-30	Amphiphilic compounds, their preparations and uses
IL228705A (en)	2016-11-30	Derivatives of Reliable Phenoxy-Ethyl, Pharmaceutical Preparations Containing and Using Them
IL238452A0 (en)	2015-06-30	History of new modified 4,1-dithienes and their use as fungicides
IL233682A0 (en)	2014-09-30	Modified phenylazole derivatives, preparations containing them and their uses
IL237540B (en)	2019-08-29	Amphiphilic compounds, their preparations and uses
IL267888B (en)	2021-02-28	Amphiphilic compounds, their preparations and uses
IL237539A0 (en)	2015-04-30	Amphiphilic compounds, their preparations and uses
IL237538B (en)	2019-11-28	Amphiphilic compounds, their preparations and uses
GB201208384D0 (en)	2012-06-27	Vesicular formulations, uses and methods
IL235312A0 (en)	2014-12-31	Taxane compounds, preparations and methods
IL227742A0 (en)	2013-09-30	Complexes of flumezenil, compounds containing them and their uses